Integrative Treatment Methods in COVID-19

Sponsor

Amasya University (Other)

Overall Status

Completed

CT.gov ID

NCT05089578

Collaborator

(none)

Enrollment

Location

Actual Duration (Months)

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study was conducted to examine the use of integrative treatment methods by individuals undergoing Covid-19. In this study, which was designed in the qualitative and phenomenological type, the criterion sampling method was used and 12 people were included in the sample.

Condition or Disease	Intervention/Treatment	Phase
COVID-19 Patient Experience Health Attitude	Other: focus interview

Detailed Description

This study was a qualitative type of phenomenological study conducted to examine the use of integrative treatment methods by individuals undergoing Covid-19. The study was completed with 12 people. The data were collected between July and October 2021. The interviews lasted for an average of 25-30 minutes. The data collected with the semi-structured interview form were analyzed by descriptive content analysis method after the interviews were over.

Study Design

Study Type:

Observational

Actual Enrollment :

12 participants

Observational Model:

Other

Time Perspective:

Cross-Sectional

Official Title:

Examination of the Use of Integrative Treatment Methods by Individuals Undergoing COVID-19 Acording to the Health Promotion Model: a Sample Qualitative Study

Actual Study Start Date :

Jul 15, 2021

Actual Primary Completion Date :

Oct 15, 2021

Actual Study Completion Date :

Oct 15, 2021

Arms and Interventions

Arm	Intervention/Treatment
Individuals with Covid-19 Interviews were conducted with individuals who had Covid-19, and their experiences with the integrative methods they used were determined.	Other: focus interview The "Information Form" including descriptive characteristics of the individuals undergoing Covid-19, the semi-structured "Interview Form", and the Complementary Therapy Use Form were used as the data collection tools. The Information Form consisted of 13 questions including socio-demographic and disease-related characteristics of individuals. In-depth interview method was used to collect data. Interviews were held by organizing video calls and online meeting programs on mobile phones both due to pandemic measures and in order to enable individuals to communicate comfortably. The time period in which the individuals felt most ready for the interview was determined and the data were collected during that time. During the interview, effective communication techniques were used, active listening was carried out and individuals were guided using question forms in accordance with the aim of the study. The interviews lasted for an average of 25-30 minutes.

Arm

Intervention/Treatment

Individuals with Covid-19

Interviews were conducted with individuals who had Covid-19, and their experiences with the integrative methods they used were determined.

Other: focus interview

The "Information Form" including descriptive characteristics of the individuals undergoing Covid-19, the semi-structured "Interview Form", and the Complementary Therapy Use Form were used as the data collection tools. The Information Form consisted of 13 questions including socio-demographic and disease-related characteristics of individuals. In-depth interview method was used to collect data. Interviews were held by organizing video calls and online meeting programs on mobile phones both due to pandemic measures and in order to enable individuals to communicate comfortably. The time period in which the individuals felt most ready for the interview was determined and the data were collected during that time. During the interview, effective communication techniques were used, active listening was carried out and individuals were guided using question forms in accordance with the aim of the study. The interviews lasted for an average of 25-30 minutes.

Outcome Measures

Primary Outcome Measures

Using integrative treatment method [15 July- October 2021]
All participants included in the study had used at least one of the integrative treatment methods.
Kind of integrative treatment methods [October 2021]
It was determined that vitamin C and medicinal plants were frequently used in addition to their medical treatments.

Eligibility Criteria

Criteria

Ages Eligible for Study:

N/A and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

individuals who underwent Covid-19 and used any of the integrative treatment methods
agreed to participate in the study constituted the sample group.

Exclusion Criteria:

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Amasya University Sciences Faculty	Amasya		Turkey	05100

Sponsors and Collaborators

Amasya University

Investigators

Principal Investigator: Gamze Fıskın, PhD, Amasya University
Principal Investigator: Nurhan Dogan, PhD, Amasya University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

nurhandogan, Asisst.Prof., Amasya University

ClinicalTrials.gov Identifier:

NCT05089578

Other Study ID Numbers:

Amasya U-2

First Posted:

Oct 22, 2021

Last Update Posted:

Oct 22, 2021

Last Verified:

Oct 1, 2021

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Keywords provided by nurhandogan, Asisst.Prof., Amasya University

Covid-19

patient experince

integrative treatment

qualitative study

health promotion model

Additional relevant MeSH terms:

COVID-19

Study Results

No Results Posted as of Oct 22, 2021